Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose esketamine + cyclopofol vs sufentanil + propofol for ERCP anesthesia in elderly patients
ChiCTR2500107838Phase 4Not yet recruiting
- Sponsor
- Quzhou People's Hospital
- Start
- Aug 2025
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine and ciprofol in biliary disease (2 arms), sponsored by Quzhou People's Hospital. Primary endpoint: Intraoperative vital sign stability. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
esketamineciprofol
03
Conditions
biliary disease
Beyond the preview
Go deeper on ChiCTR2500107838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107838.